全文获取类型
收费全文 | 1330篇 |
免费 | 209篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 25篇 |
妇产科学 | 15篇 |
基础医学 | 57篇 |
口腔科学 | 20篇 |
临床医学 | 371篇 |
内科学 | 204篇 |
皮肤病学 | 5篇 |
神经病学 | 46篇 |
特种医学 | 1篇 |
外科学 | 34篇 |
综合类 | 32篇 |
一般理论 | 1篇 |
预防医学 | 226篇 |
眼科学 | 20篇 |
药学 | 465篇 |
中国医学 | 9篇 |
肿瘤学 | 9篇 |
出版年
2024年 | 1篇 |
2023年 | 25篇 |
2022年 | 43篇 |
2021年 | 76篇 |
2020年 | 87篇 |
2019年 | 87篇 |
2018年 | 74篇 |
2017年 | 77篇 |
2016年 | 57篇 |
2015年 | 71篇 |
2014年 | 81篇 |
2013年 | 130篇 |
2012年 | 60篇 |
2011年 | 65篇 |
2010年 | 54篇 |
2009年 | 55篇 |
2008年 | 63篇 |
2007年 | 69篇 |
2006年 | 47篇 |
2005年 | 60篇 |
2004年 | 47篇 |
2003年 | 28篇 |
2002年 | 29篇 |
2001年 | 35篇 |
2000年 | 17篇 |
1999年 | 15篇 |
1998年 | 9篇 |
1997年 | 10篇 |
1996年 | 6篇 |
1995年 | 1篇 |
1994年 | 9篇 |
1993年 | 6篇 |
1992年 | 6篇 |
1991年 | 7篇 |
1990年 | 3篇 |
1989年 | 8篇 |
1988年 | 2篇 |
1987年 | 2篇 |
1985年 | 2篇 |
1984年 | 1篇 |
1983年 | 5篇 |
1981年 | 5篇 |
1980年 | 1篇 |
1979年 | 3篇 |
1977年 | 1篇 |
1976年 | 1篇 |
排序方式: 共有1541条查询结果,搜索用时 15 毫秒
1.
2.
3.
《Journal of the American Medical Directors Association》2020,21(2):172-180.e5
IntroductionOlder age is associated with multimorbidity and polypharmacy with high anticholinergic burden (ACB). High ACB is linked to adverse events such as poor physical functioning, dementia, cardiovascular disease, and falls. Interventions are needed to reduce this burden.Aims/ObjectivesThe aim was to systematically review the literature to identify and describe studies of clinical and cost-effectiveness of interventions designed to reduce ACB in adults (≥65 years) on polypharmacy regimes, compared with usual care. The objective was to answer the following questions: What are the contents of the interventions? Were these interventions clinically effective? Were these interventions cost effective?.Design, setting, and participantsSystematic review of interventions to reduce anticholinergic burden in adults aged 65 and older in any clinical setting.MethodsEligible papers reported primary or secondary research describing any type of intervention including systematic reviews, randomized controlled trials (RCTs), controlled clinical trials, or nonrandomized pre-post intervention studies (PPIs) published in English from January 2010 to February 2019. Databases searched included CINAHL, Ovid MEDLINE, EMBASE, and The Cochrane Central Register of Controlled Trials (CENTRAL).ResultsThe search yielded 5862 records. Eight studies (4 RCTs, 4 PPIs) conducted in hospital (4), community (2), nursing homes (1), and retirement villages (1) met the inclusion criteria. Pharmacists, either individually or as part of a team, provided the intervention in the majority of studies (6/8). Most (7/8) involved individual patient medication review followed by feedback to the prescriber. Two of the 4 RCTs and all non-RCTs reported a decrease in ACB following the intervention. No study reported cost outcome.Conclusions/ImplicationsPharmacists may be well placed to implement an ACB reduction intervention. This is the first systematic review of interventions to reduce ACB in older adults, and it highlights the need for development and testing of high-quality pragmatic clinical and cost-effectiveness trials in community and specific patient populations at high risk of harm from ACB.[PROSPERO registration: CRD42018089764]. 相似文献
4.
《The Journal for Nurse Practitioners》2020,16(4):258-261
Prescribing of proton pump inhibitors (PPIs) has markedly increased since their inception more than 30 years ago. The increase is related to inappropriate and long-term prescribing of PPIs, associated with a lack of education and unclear prescribing and deprescribing guidelines. The implementation of prescribing stewardship programs influences the reduction and inappropriate use of this medication. The purpose of this review is to address the gaps that exist regarding the use of PPIs along with determining methods for deprescribing. Guidelines and stewardship programs, along with education, are needed to reduce the adverse health effects of long-term PPI therapy. 相似文献
5.
6.
7.
8.
9.
10.